(Q46812189)

English

Platelet-derived growth factor receptor alpha mutational status and immunohistochemical expression in Merkel cell carcinoma: implications for treatment with imatinib mesylate

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18190445

Platelet-derived growth factor receptor alpha mutational status and immunohistochemical expression in Merkel cell carcinoma: implications for treatment with imatinib mesylate (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18190445

immunohistochemistry

1 reference

based on heuristic

inferred from title

Merkel cell carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Brian L Swick

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18190445

Larisa Ravdel

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18190445

James E Fitzpatrick

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18190445

William A Robinson

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18190445

publication date

1 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18190445

Journal of Cutaneous Pathology

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18190445

35

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18190445

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18190445

197-202

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18190445

Structure, organization, and transcription units of the human alpha-platelet-derived growth factor receptor gene, PDGFRA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

Receptor tyrosine kinases as targets for anticancer drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor Beta

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

Activating mutations in c-KIT and PDGFRalpha are exclusively found in gastrointestinal stromal tumors and not in other tumors overexpressing these imatinib mesylate target genes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

Imatinib mesylate--a new oral targeted therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

Targeted therapy with imatinib: hits and misses?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

PDGFRA activating mutations in gastrointestinal stromal tumors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

CD117 (KIT receptor) expression in Merkel cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

KIT receptor (CD117) expression in Merkel cell carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

CD117, CK20, TTF-1, and DNA topoisomerase II-alpha antigen expression in small cell tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

c-kit expression in primary and metastatic merkel cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

GISTs with PDGFRA exon 14 mutations represent subset of clinically favorable gastric tumors with epithelioid morphology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

Platelet-derived growth factor receptor-alpha-associated hypereosinophilic syndrome and lymphomatoid papulosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

Imatinib mesylate: an attractive alternative in young children with large, surgically challenging dermatofibrosarcoma protuberans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

Sustained complete remission of metastatic dermatofibrosarcoma protuberans with imatinib mesylate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00793.X

21 January 2018

Identifiers

10.1111/J.1600-0560.2007.00793.X

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18190445

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18190445

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46812189&oldid=2133168412"